2014;99(3):E41826
For patients with first-time anti-obesity medication prescriptions in March 2025, only 46.8% had evidence of a prescription fill within 60 days, compared to 72.2% of patients receiving anti-diabetic medication prescriptions
The peptide sequence and its fatty acid conjugation create a half-life of approximately six days, which enables once-weekly dosing in clinical protocols
Tirzepatide produced greater average weight reduction in the direct SURMOUNT-5 obesity trial, with mean weight loss of 20.2% compared with 13.7% for semaglutide at 72 weeks
This reduction in inflammation may explain some of the improvements in joint pain and energy that users report during the early months of treatment
Unfortunately, in some cases people dont know exactly what they are receiving when purchasing these products. Tenille Davis, PharmD, RPh, BCSCP, FAPC, chief advocacy officer for the Alliance for Pharmacy Compounding, said compounding pharmacies are beholden to regulations within their respective states